A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab
Clinical trial NCT04048577 · UNKNOWN
Trial details
- NCT number
- NCT04048577
- Sponsor
- Berkovich, Regina MD, PhD Inc.
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-03
- Primary completion
- 2021-11-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.